tiprankstipranks
Enlivex Therapeutics Ltd (ENLV)
NASDAQ:ENLV
US Market

Enlivex (ENLV) Financial Statements

Compare
421 Followers

Enlivex Financial Overview

Enlivex's market cap is currently $23.09M. The company's EPS TTM is $-0.99; its P/E ratio is ―; Enlivex is scheduled to report earnings on May 23, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 2.28M$ 0.00
Gross Profit$ -835.00K$ -777.00K$ -546.00K$ 1.99M$ -297.00K
Operating Income$ -29.39M$ -25.80M$ -19.29M$ -9.79M$ -8.62M
EBITDA$ -28.22M$ -25.02M$ -18.74M$ -9.50M$ -9.08M
Net Income$ -29.07M$ -42.41M$ -9.65M$ -13.86M$ -10.15M
Balance Sheet
Cash & Short-Term Investments$ 27.32M$ 48.12M$ 84.13M$ 35.71M$ 12.01M
Total Assets$ 36.83M$ 67.64M$ 95.15M$ 40.36M$ 17.56M
Total Debt$ 1.03M$ 4.85M$ 617.00K$ 203.00K$ 123.00K
Net Debt$ 219.00K$ -42.98M$ -10.59M$ -5.47M$ -3.83M
Total Liabilities$ 6.75M$ 10.80M$ 10.11M$ 4.87M$ 6.28M
Stockholders' Equity$ 30.08M$ 56.84M$ 85.04M$ 35.49M$ 11.28M
Cash Flow
Free Cash Flow$ -23.76M$ -32.08M$ -19.17M$ -12.03M$ -7.23M
Operating Cash Flow$ -23.52M$ -23.95M$ -17.54M$ -11.01M$ -7.04M
Investing Cash Flow$ -25.97M$ 62.52M$ -38.41M$ -20.98M$ -6.36M
Financing Cash Flow$ 360.00K$ 150.00K$ 60.98M$ 33.08M$ 8.31M
Currency in USD

Enlivex Earnings and Revenue History

Enlivex Debt to Assets

Enlivex Cash Flow

Enlivex Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis